Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078680 | SCV000110540 | benign | not specified | 2013-10-16 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000078680 | SCV000151852 | benign | not specified | 2015-02-23 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000659859 | SCV000604226 | benign | X-linked Opitz G/BBB syndrome | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659859 | SCV000781739 | uncertain significance | X-linked Opitz G/BBB syndrome | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311555 | SCV000847177 | benign | Inborn genetic diseases | 2015-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000950878 | SCV001097218 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000950878 | SCV004166096 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | MID1: BS2 |